company background image
688767 logo

Hangzhou Biotest BiotechLtd SHSE:688767 Stock Report

Last Price

CN¥24.79

Market Cap

CN¥2.6b

7D

-8.4%

1Y

-42.6%

Updated

27 Mar, 2024

Data

Company Financials

Hangzhou Biotest Biotech Co.,Ltd.

SHSE:688767 Stock Report

Market Cap: CN¥2.6b

688767 Stock Overview

Hangzhou Biotest Biotech Co., LTD. engages in the research and development, manufacture, sale, and service of in vitro diagnostic assays and reagents, and instruments in China and internationally.

688767 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance2/6
Financial Health5/6
Dividends2/6

Hangzhou Biotest Biotech Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Hangzhou Biotest BiotechLtd
Historical stock prices
Current Share PriceCN¥24.79
52 Week HighCN¥43.93
52 Week LowCN¥22.23
Beta0.46
1 Month Change-7.47%
3 Month Change-17.09%
1 Year Change-42.58%
3 Year Changen/a
5 Year Changen/a
Change since IPO-67.86%

Recent News & Updates

Recent updates

Shareholder Returns

688767CN BiotechsCN Market
7D-8.4%-4.9%-2.2%
1Y-42.6%-20.7%-14.8%

Return vs Industry: 688767 underperformed the CN Biotechs industry which returned -20.7% over the past year.

Return vs Market: 688767 underperformed the CN Market which returned -14.8% over the past year.

Price Volatility

Is 688767's price volatile compared to industry and market?
688767 volatility
688767 Average Weekly Movement5.4%
Biotechs Industry Average Movement8.0%
Market Average Movement8.1%
10% most volatile stocks in CN Market11.4%
10% least volatile stocks in CN Market5.1%

Stable Share Price: 688767's share price has been volatile over the past 3 months.

Volatility Over Time: 688767's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2008665Shujiang Wuhttps://www.biotests.com.cn

Hangzhou Biotest Biotech Co., LTD. engages in the research and development, manufacture, sale, and service of in vitro diagnostic assays and reagents, and instruments in China and internationally. The company offers medical test products for fertility health, cardiology, oncology, inflammation, biochemistry, and various infectious diseases.

Hangzhou Biotest Biotech Co.,Ltd. Fundamentals Summary

How do Hangzhou Biotest BiotechLtd's earnings and revenue compare to its market cap?
688767 fundamental statistics
Market capCN¥2.64b
Earnings (TTM)CN¥111.27m
Revenue (TTM)CN¥442.36m

23.8x

P/E Ratio

6.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
688767 income statement (TTM)
RevenueCN¥442.36m
Cost of RevenueCN¥0
Gross ProfitCN¥442.36m
Other ExpensesCN¥331.10m
EarningsCN¥111.27m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 27, 2024

Earnings per share (EPS)1.04
Gross Margin100.00%
Net Profit Margin25.15%
Debt/Equity Ratio0.1%

How did 688767 perform over the long term?

See historical performance and comparison

Dividends

8.9%

Current Dividend Yield

-1,195%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.